These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 10921314)
21. Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer. Shiri-Sverdlov R; Oefner P; Green L; Baruch RG; Wagner T; Kruglikova A; Haitchick S; Hofstra RM; Papa MZ; Mulder I; Rizel S; Bar Sade RB; Dagan E; Abdeen Z; Goldman B; Friedman E Hum Mutat; 2000 Dec; 16(6):491-501. PubMed ID: 11102978 [TBL] [Abstract][Full Text] [Related]
22. Genetics and ovarian carcinoma. Lynch HT; Casey MJ; Lynch J; White TE; Godwin AK Semin Oncol; 1998 Jun; 25(3):265-80. PubMed ID: 9633840 [TBL] [Abstract][Full Text] [Related]
23. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
24. Mutations of the BRCA1 and BRCA2 genes and the possibilities for predictive testing. Gayther SA; Ponder BA Mol Med Today; 1997 Apr; 3(4):168-74. PubMed ID: 9134530 [TBL] [Abstract][Full Text] [Related]
26. BRCA1 and BRCA2: from molecular genetics to clinical medicine. Blackwood MA; Weber BL J Clin Oncol; 1998 May; 16(5):1969-77. PubMed ID: 9586917 [TBL] [Abstract][Full Text] [Related]
27. Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. Online. De Benedetti VM; Radice P; Pasini B; Stagi L; Pensotti V; Mondini P; Manoukian S; Conti A; Spatti G; Rilke F; Pierotti MA Hum Mutat; 1998; 12(3):215. PubMed ID: 10660329 [TBL] [Abstract][Full Text] [Related]
28. BRCA1 and BRCA2 mutations in central and southern Italian patients. Ottini L; D'Amico C; Noviello C; Lauro S; Lalle M; Fornarini G; Colantuoni OA; Pizzi C; Cortesi E; Carlini S; Guadagni F; Bianco AR; Frati L; Contegiacomo A; Mariani-Costantini R Breast Cancer Res; 2000; 2(4):307-10. PubMed ID: 11056688 [TBL] [Abstract][Full Text] [Related]
29. Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families. Giannini G; Capalbo C; Ristori E; Ricevuto E; Sidoni T; Buffone A; Cortesi E; Marchetti P; Scambia G; Tomao S; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A Breast Cancer Res Treat; 2006 Nov; 100(1):83-91. PubMed ID: 16847550 [TBL] [Abstract][Full Text] [Related]
30. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium. Lancet; 1997 May; 349(9064):1505-10. PubMed ID: 9167459 [TBL] [Abstract][Full Text] [Related]
31. Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families. Osorio A; Barroso A; Martínez B; Cebrián A; San Román JM; Lobo F; Robledo M; Benítez J Br J Cancer; 2000 Apr; 82(7):1266-70. PubMed ID: 10755399 [TBL] [Abstract][Full Text] [Related]
32. Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations. Khoo US; Ngan HY; Cheung AN; Chan KY; Lu J; Chan VW; Lau S; Andrulis IL; Ozcelik H Hum Mutat; 2000 Jul; 16(1):88-9. PubMed ID: 10874312 [TBL] [Abstract][Full Text] [Related]
33. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer. Fourati A; Louchez MM; Fournier J; Gamoudi A; Rahal K; El May MV; El May A; Revillion F; Peyrat JP Bull Cancer; 2014 Nov; 101(11):E36-40. PubMed ID: 25418591 [TBL] [Abstract][Full Text] [Related]
34. [The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada]. Tonin PN Bull Cancer; 2006 Sep; 93(9):841-6. PubMed ID: 16980226 [TBL] [Abstract][Full Text] [Related]
35. New BRCA2 mutation in an Ashkenazi Jewish family with breast and ovarian cancer. Robson ME; Offit K Lancet; 1997 Jul; 350(9071):117-8. PubMed ID: 9228974 [No Abstract] [Full Text] [Related]
37. BRCA1/2 mutations in Swiss patients with familial or early-onset breast and ovarian cancer. Schoumacher F; Glaus A; Mueller H; Eppenberger U; Bolliger B; Senn HJ Swiss Med Wkly; 2001 Apr; 131(15-16):223-6. PubMed ID: 11400546 [TBL] [Abstract][Full Text] [Related]
38. Laboratory identification of hereditary risk of breast and ovarian cancer. Frank TS Curr Opin Biotechnol; 1999 Jun; 10(3):289-94. PubMed ID: 10361081 [No Abstract] [Full Text] [Related]
39. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations. Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145 [TBL] [Abstract][Full Text] [Related]
40. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals. Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]